首页 | 本学科首页   官方微博 | 高级检索  
检索        

血液透析患者输血前后抗-HCV的追踪检测
引用本文:郑兰香,刘竞.血液透析患者输血前后抗-HCV的追踪检测[J].实用预防医学,2003,10(1):24-25.
作者姓名:郑兰香  刘竞
作者单位:中南大学湘雅三医院检验科,中国湖南,长沙,410013
摘    要:目的:了解血液透析患者输血前后HCV感染情况。方法:采用ELISA法进行抗-HCV检测。结果:116例血液透析患者抗-HCV阳性率为13.79%,输血组输血前与未输血组比较无显著性差异,追踪检测输血后6、12、18、24个月病例,随着血液透析时间延长,抗-HCV阳性率增高,但输血组与未输血组比较仍无差异。结论:血液透析患者与输血前后抗-HCV阳性率无明显差异,输血不增加感染HCV的风险。

关 键 词:血液透析  输血  抗-HCV  丙型肝炎病毒  ELISA法
文章编号:1006-3110(2003)01-0024-02
修稿时间:2002年11月23

A Follow-up Examination of Anti-HCV in Haemodialysis Patients Before and After Blood Transfusion
Zhen Lanxiang,Liu Jing.A Follow-up Examination of Anti-HCV in Haemodialysis Patients Before and After Blood Transfusion[J].Practical Preventive Medicine,2003,10(1):24-25.
Authors:Zhen Lanxiang  Liu Jing
Abstract:Objective To know about the situation of HCV infection in haemodialysis patients before and after blood transfusion. Methods ELISA was adopted to detect anti-HCV. Result The positive rate of anti-HCV was 13.79% in 116 haemodialysis cases, showing no significant difference between blood transfusion group and non blood transfusion group. The positive rate of anti-HCV rises with the interval after baemodialysis in cases 6,12,8 and 24 months after receiving blood transfusion. No difference was demonstrated in blood transfusion and non-blood transfusion group. Conclusion The positive rate of anti-HCV has no significant difference in haemodialysis patients before and after blood transfusion. Blood transfusion doesn't increase the risk of HCV infection.
Keywords:Laboratory diagnostics  Haemodialysis patient  Blood transfusion  Anti-HCV
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号